Brief: LifeMD Sees FY revenue USD 148-149 million
08/11/2023 22:52
Nov 8 (Reuters) - LifeMD Q3 revenue USD 38.6 million vs. IBES estimate USD 38.2 million. * Outlook FY revenue USD 148-149 million * Q3 adjusted EPS USD 0.08 * Q3 gross margin 88% * Outlook FY adjusted EBITDA USD 10-11 million * Q3 adjusted EBITDA USD 2.8 million * Q3 net income USD -6.9 million
Recent news on LifeMD
See all newsLifeMD Q1 revenue beats estimates on record telehealth subscriber additons
Brief: LifeMD Q1 Adjusted EBITDA USD -4.5 Million Vs. IBES Estimate USD -4.66 Million
LifeMD rises after adding new daily obesity pill to weight management program
Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US (updated)
Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US